These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oncogenes and tumor suppressor genes. Liu E; Weissman B Cancer Treat Res; 1992; 63():1-13. PubMed ID: 1363351 [No Abstract] [Full Text] [Related]
3. [Genetics and cancer]. Cardesa JJ; Blesa E; Durán J; Moreno F; Espinosa J; Zarallo L An Esp Pediatr; 1985 Aug; 23(2):116-22. PubMed ID: 2998249 [No Abstract] [Full Text] [Related]
4. Genetics of cancer predisposition. Hansen MF; Cavenee WK Cancer Res; 1987 Nov; 47(21):5518-27. PubMed ID: 2889524 [No Abstract] [Full Text] [Related]
5. [From oncogene to anti-oncogene. Recent findings apropos of the retinoblastoma susceptibility gene]. Harel J Bull Cancer; 1989; 76(4):339-46. PubMed ID: 2665876 [No Abstract] [Full Text] [Related]
6. Retinoblastoma and cancer genetics. Gilbert F N Engl J Med; 1986 May; 314(19):1248-50. PubMed ID: 3702921 [No Abstract] [Full Text] [Related]
7. Genetics of human cancer. Knudson AG J Cell Physiol Suppl; 1986; 4():7-11. PubMed ID: 3528184 [No Abstract] [Full Text] [Related]
8. Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma. Tarkkanen A; Karjalainen K Ophthalmologica; 1984; 189(3):143-6. PubMed ID: 6493695 [TBL] [Abstract][Full Text] [Related]
9. Cancer: genetic and nutritional aspects. Friend S World Rev Nutr Diet; 1990; 63():131-42. PubMed ID: 2197792 [No Abstract] [Full Text] [Related]
10. Hereditary cancer, oncogenes, and antioncogenes. Knudson AG Cancer Res; 1985 Apr; 45(4):1437-43. PubMed ID: 2983882 [No Abstract] [Full Text] [Related]
11. The marriage of oncogenes and anti-oncogenes. Linzer DI Trends Genet; 1988 Sep; 4(9):245-7. PubMed ID: 3070870 [No Abstract] [Full Text] [Related]
12. Contribution and mechanisms of genetic predisposition to cancer: hereditary cancers and anti-oncogenes. Knudson AG Prog Clin Biol Res; 1983; 132C():351-60. PubMed ID: 6314359 [No Abstract] [Full Text] [Related]
14. [Recessive oncogene and loss of heterozygosity]. Sasaki M; Ejima Y; Ishizaki K; Toguchida J; Kato M Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):624-31. PubMed ID: 2650634 [TBL] [Abstract][Full Text] [Related]
16. Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Bookstein R; Lee EY; To H; Young LJ; Sery TW; Hayes RC; Friedmann T; Lee WH Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2210-4. PubMed ID: 2895471 [TBL] [Abstract][Full Text] [Related]
18. N-myc amplified in retinoblastoma cell line FMC-RB1. Seshadri R; Matthews C; Norris MD; Brian MJ Cancer Genet Cytogenet; 1988 Jul; 33(1):25-7. PubMed ID: 2838158 [TBL] [Abstract][Full Text] [Related]
19. Anti-oncogenes and the negative regulation of cell growth. Horowitz JM; Friend SH; Weinberg RA; Whyte P; Buchkovich K; Harlow E Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():843-7. PubMed ID: 2908198 [No Abstract] [Full Text] [Related]
20. [A gene inhibiting the development of human retinoblastoma: the prototype of tumor suppressor genes]. Uzvölgyi E; Kertai P Orv Hetil; 1990 Jun; 131(24):1287-90. PubMed ID: 2195424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]